FR2975301B1 - Composition comprenant un interferon alpha - Google Patents
Composition comprenant un interferon alphaInfo
- Publication number
- FR2975301B1 FR2975301B1 FR1154416A FR1154416A FR2975301B1 FR 2975301 B1 FR2975301 B1 FR 2975301B1 FR 1154416 A FR1154416 A FR 1154416A FR 1154416 A FR1154416 A FR 1154416A FR 2975301 B1 FR2975301 B1 FR 2975301B1
- Authority
- FR
- France
- Prior art keywords
- glutamic acid
- composition
- interferon alpha
- grafted poly
- mol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1154416A FR2975301B1 (fr) | 2011-05-20 | 2011-05-20 | Composition comprenant un interferon alpha |
US13/472,675 US20120294832A1 (en) | 2011-05-20 | 2012-05-16 | Composition comprising interferon alpha |
PCT/IB2012/052459 WO2012160485A1 (fr) | 2011-05-20 | 2012-05-16 | Composition comprenant de l'interféron alpha |
ARP120101764A AR086449A1 (es) | 2011-05-20 | 2012-05-18 | COMPOSICION QUE COMPRENDE INTERFERON a |
UY0001034083A UY34083A (es) | 2011-05-20 | 2012-05-18 | Composición que comprende interferón alfa para ciertos tipos de cáncer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1154416A FR2975301B1 (fr) | 2011-05-20 | 2011-05-20 | Composition comprenant un interferon alpha |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2975301A1 FR2975301A1 (fr) | 2012-11-23 |
FR2975301B1 true FR2975301B1 (fr) | 2013-05-24 |
Family
ID=46208119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1154416A Expired - Fee Related FR2975301B1 (fr) | 2011-05-20 | 2011-05-20 | Composition comprenant un interferon alpha |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR086449A1 (fr) |
FR (1) | FR2975301B1 (fr) |
UY (1) | UY34083A (fr) |
WO (1) | WO2012160485A1 (fr) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5980948A (en) * | 1996-08-16 | 1999-11-09 | Osteotech, Inc. | Polyetherester copolymers as drug delivery matrices |
FR2801226B1 (fr) | 1999-11-23 | 2002-01-25 | Flamel Tech Sa | Suspension colloidale de particules submicroniques de vectorisation de principes actifs et son mode de preparation |
FR2840614B1 (fr) | 2002-06-07 | 2004-08-27 | Flamel Tech Sa | Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques |
FR2862541B1 (fr) * | 2003-11-21 | 2007-04-20 | Flamel Tech Sa | Formulations pharmaceutiques pour la liberation prolongee d'interferons et leurs applications therapeutiques |
MX2011008963A (es) * | 2009-03-05 | 2012-02-01 | Ascendis Pharma As | Profarmacos portadores de interferon alfa. |
-
2011
- 2011-05-20 FR FR1154416A patent/FR2975301B1/fr not_active Expired - Fee Related
-
2012
- 2012-05-16 WO PCT/IB2012/052459 patent/WO2012160485A1/fr active Application Filing
- 2012-05-18 UY UY0001034083A patent/UY34083A/es unknown
- 2012-05-18 AR ARP120101764A patent/AR086449A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FR2975301A1 (fr) | 2012-11-23 |
WO2012160485A1 (fr) | 2012-11-29 |
AR086449A1 (es) | 2013-12-11 |
UY34083A (es) | 2013-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120994T1 (el) | Καινοτομες συνθεσεις διαλυματος που περιεχουν κυτταρικο παραγοντα και χρηση αυτων για τη θεραπεια τραυματων | |
CY1122251T1 (el) | Αιμοστατικες συνθεσεις | |
EP4349405A3 (fr) | Vaccins contre le virus respiratoire | |
GB201112382D0 (en) | Curable compositions and membranes | |
EP3342840A3 (fr) | Compositions et utilisations de cis-1,1,1,4,4,4-hexafluorobut-2-ène | |
MA32394B1 (fr) | Composes pegyles d'insuline lispro | |
WO2008036932A3 (fr) | Compositions et procédés utilisant l'espèce boswellia | |
EA201390600A1 (ru) | Терапевтические наночастицы с сополимерами с большим молекулярным весом | |
MY160722A (en) | Preparing high order hydridosilane compounds | |
MX360107B (es) | Formulación de acción rápida de insulina que comprende un compuesto aniónico sustituido. | |
EP2561855A3 (fr) | Procédé de modification chimique de la région interne de la tige d'un poil | |
EP2565326A4 (fr) | Composition inhibitrice de contamination | |
MX362199B (es) | Compuestos y composiciones de poliglicerilo cationicos. | |
EA200870174A1 (ru) | Отверждающие агенты для эпокси-функциональных соединений | |
ZA200707973B (en) | Low amounts of high molecular weight polymer for enhancing viscosity of aqueous/aqueous biphasic liquids | |
WO2016081112A3 (fr) | Agent de rétention d'eau synthétique et modificateur de rhéologie destinés à être utilisés dans des additifs, ciments | |
NZ701463A (en) | Anti-phytopathogenic composition | |
MX2016003441A (es) | Metodos para producir acidos poliasparticos. | |
WO2012174096A3 (fr) | Compositions de soins personnels comprenant un agent gélifiant di-amido et procédés d'utilisation | |
MX2009000768A (es) | Lactamas macrociclicas. | |
BR112015009453A2 (pt) | composição farmacêutica estável de peg-interferona alfa-2b | |
JP2010053171A5 (fr) | ||
IN2013MU03773A (fr) | ||
RU2008116559A (ru) | Хлорсодержащие ароматические олигоэфиры | |
FR2975301B1 (fr) | Composition comprenant un interferon alpha |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20160129 |